
Forward Therapeutics
Forward Therapeutics: Innovating chronic inflammatory treatment through advanced oral immune therapies.
- 2
- Series A
Forward Therapeutics, a biopharmaceutical company, is dedicated to transforming the treatment of chronic inflammatory disorders through advanced oral immune therapies. The company's core mission is to develop next-generation small molecule therapies that can significantly improve patient care. Their market focus is on delivering blockbuster oral agents that target validated immunology pathways, aiming to provide effective and convenient treatment options for patients suffering from chronic inflammatory conditions.
Notable figures associated with Forward Therapeutics include leading scientific experts in immunology and drug development. The company has achieved significant milestones in its integrated discovery and development processes, leveraging cutting-edge capabilities to advance its pipeline. Forward Therapeutics' impact lies in its potential to revolutionize patient care by offering innovative oral therapies that address unmet medical needs in chronic inflammation.
Similar Companies

SFA Therapeutics

Rise Therapeutics

i2o Therapeutics
i2obio.com

Azora Therapeutics

Invea Therapeutics
inveatx.com
Orion BioScience

Syntis Bio
syntis.bio

Intrommune Therapeutics
intrommune.com

Lapix Therapeutics
lapix.com

Janus Biotherapeutics

InflammX Therapeutics
inflammx.com

Rapt Therapeutics
rapt.com

CarthroniX
carthronix.com

Sorriso Pharmaceuticals
sorrisopharma.com

Evommune
evommune.com
Quick Facts
Who are Forward Therapeutics' competitors?
Companies similar to Forward Therapeutics include SFA Therapeutics, Rise Therapeutics, i2o Therapeutics and Azora Therapeutics.
When was Forward Therapeutics founded?
Forward Therapeutics was founded in 2022.
Where is Forward Therapeutics' headquarters located?
Forward Therapeutics' headquarters is located in Palm Beach Gardens, FL, US.
When was Forward Therapeutics' last funding round?
Forward Therapeutics' most recent funding round was for $50M (USD) in November 2023.
How much disclosed funding has Forward Therapeutics raised?
As of Nov 8, 2023, Forward Therapeutics has disclosed funding of $50M (USD). Undisclosed round amounts are excluded.
How many employees does Forward Therapeutics have?
Forward Therapeutics has 2 employees as of Feb 4, 2024.
Classification
- Ownership
- Technology
- Geographic Exposure
- Customer
- Main Product
- Tags
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8730Research, Development, And Testing Services
- 8731Commercial Physical and Biological Research
Show 12 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 2800Chemicals And Allied Products
- 8000Health Services
- 2830Drugs
- 8040Offices And Clinics Of Other Health Practitioners
- 2834Pharmaceutical Preparations
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified